Matches in SemOpenAlex for { <https://semopenalex.org/work/W199227545> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W199227545 endingPage "7" @default.
- W199227545 startingPage "142" @default.
- W199227545 abstract "The study was designed to investigate proliferation inhibition for cervical adenocarcinoma HeLa cell treated with cisplatin combined with mifepristone and access its possible mechanism.HeLa cell was processed by different concentrations of mifepristone, cisplatin, and their combination respectively. Cell's proliferation inhibition rate and induction apoptosis ability were detected by MTT assay, FCM; the expression of P53, survivin and HPV E6 protein were measured by Western Blot.The results showed that cisplatin inhibits proliferation of HeLa cells in different concentrations (p <0.01). Mifepristone had no effect on HeLa cell proliferation inhibition rate during 24 and 48 hours (p > 0.05). Mifepristone at low concentrations (< or = 10 micromol/l) combined with cisplatin can significantly enhance the inhibitory effect of cisplatin on HeLa cell line. Flow cytometry showed that mifepristone at low concentrations (< or = 10 micromol/l) combined with cisplatin can induce apparent apoptosis of HeLa cell line in concentration dependent manner. Western blotting demonstrated that the expression of P53 protein increased and the expression of HPV E6 survivin protein decreased in HeLa cells treated with MIF at low concentrations (< or = 10 micromol/l) combined with cisplatin.Mifepristone at low concentrations (< or = 10 micromol/1) can enhance chemosensitivity and capability of inducing apoptosis of cisplatin to HeLa cells. The strengthening effect of growth inhibition and chemosensitivity to cisplatin of mifepristone are associated with down-regulating HPV E6 survivin protein and upregulating p53 protein." @default.
- W199227545 created "2016-06-24" @default.
- W199227545 creator A5000594791 @default.
- W199227545 creator A5078059635 @default.
- W199227545 date "2013-01-01" @default.
- W199227545 modified "2023-09-26" @default.
- W199227545 title "Mifepristone sensitizing cisplatin for cervical adenocarcinoma HeLa cell sensitivity to chemotherapy and its mechanism." @default.
- W199227545 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23781585" @default.
- W199227545 hasPublicationYear "2013" @default.
- W199227545 type Work @default.
- W199227545 sameAs 199227545 @default.
- W199227545 citedByCount "3" @default.
- W199227545 countsByYear W1992275452015 @default.
- W199227545 countsByYear W1992275452016 @default.
- W199227545 countsByYear W1992275452018 @default.
- W199227545 crossrefType "journal-article" @default.
- W199227545 hasAuthorship W199227545A5000594791 @default.
- W199227545 hasAuthorship W199227545A5078059635 @default.
- W199227545 hasConcept C104317684 @default.
- W199227545 hasConcept C126322002 @default.
- W199227545 hasConcept C1491633281 @default.
- W199227545 hasConcept C153911025 @default.
- W199227545 hasConcept C185592680 @default.
- W199227545 hasConcept C190283241 @default.
- W199227545 hasConcept C2775975398 @default.
- W199227545 hasConcept C2776415932 @default.
- W199227545 hasConcept C2776694085 @default.
- W199227545 hasConcept C2777366897 @default.
- W199227545 hasConcept C2778239845 @default.
- W199227545 hasConcept C2778826759 @default.
- W199227545 hasConcept C2779234561 @default.
- W199227545 hasConcept C2780783641 @default.
- W199227545 hasConcept C29537977 @default.
- W199227545 hasConcept C502942594 @default.
- W199227545 hasConcept C54355233 @default.
- W199227545 hasConcept C55493867 @default.
- W199227545 hasConcept C62112901 @default.
- W199227545 hasConcept C71924100 @default.
- W199227545 hasConcept C81885089 @default.
- W199227545 hasConcept C86803240 @default.
- W199227545 hasConceptScore W199227545C104317684 @default.
- W199227545 hasConceptScore W199227545C126322002 @default.
- W199227545 hasConceptScore W199227545C1491633281 @default.
- W199227545 hasConceptScore W199227545C153911025 @default.
- W199227545 hasConceptScore W199227545C185592680 @default.
- W199227545 hasConceptScore W199227545C190283241 @default.
- W199227545 hasConceptScore W199227545C2775975398 @default.
- W199227545 hasConceptScore W199227545C2776415932 @default.
- W199227545 hasConceptScore W199227545C2776694085 @default.
- W199227545 hasConceptScore W199227545C2777366897 @default.
- W199227545 hasConceptScore W199227545C2778239845 @default.
- W199227545 hasConceptScore W199227545C2778826759 @default.
- W199227545 hasConceptScore W199227545C2779234561 @default.
- W199227545 hasConceptScore W199227545C2780783641 @default.
- W199227545 hasConceptScore W199227545C29537977 @default.
- W199227545 hasConceptScore W199227545C502942594 @default.
- W199227545 hasConceptScore W199227545C54355233 @default.
- W199227545 hasConceptScore W199227545C55493867 @default.
- W199227545 hasConceptScore W199227545C62112901 @default.
- W199227545 hasConceptScore W199227545C71924100 @default.
- W199227545 hasConceptScore W199227545C81885089 @default.
- W199227545 hasConceptScore W199227545C86803240 @default.
- W199227545 hasIssue "2" @default.
- W199227545 hasLocation W1992275451 @default.
- W199227545 hasOpenAccess W199227545 @default.
- W199227545 hasPrimaryLocation W1992275451 @default.
- W199227545 hasRelatedWork W1982537336 @default.
- W199227545 hasRelatedWork W2351405740 @default.
- W199227545 hasRelatedWork W2364418237 @default.
- W199227545 hasRelatedWork W2366747601 @default.
- W199227545 hasRelatedWork W2368940306 @default.
- W199227545 hasRelatedWork W2374067319 @default.
- W199227545 hasRelatedWork W2376727181 @default.
- W199227545 hasRelatedWork W2378203004 @default.
- W199227545 hasRelatedWork W2383691845 @default.
- W199227545 hasRelatedWork W2393452455 @default.
- W199227545 hasVolume "34" @default.
- W199227545 isParatext "false" @default.
- W199227545 isRetracted "false" @default.
- W199227545 magId "199227545" @default.
- W199227545 workType "article" @default.